Reproductive
Health
Regenerative
Health
Longevity
HealthComprehensive
Reproductive Health
Testing Services
20+ Years of Trusted
Reproductive Health Expertise
We have tested 24,000+ embryos, genetically screened 45,000+ pregnancies, and stored 23,000+ newborn stem cell units.
We believe in the power of informed decisions. By taking ownership of your reproductive health, you can grow and protect your family’s future health. We are here to help you navigate every step, empowering you to create the future you envision for your loved ones.
Let us help you create your family's future
With over 20 years of experience, Next Biosciences provides advanced reproductive health testing in South Africa, offering fertility screening, pregnancy genetic testing, and prenatal screening solutions designed to support families from preconception through pregnancy. Our scientifically backed services are developed to meet the unique needs of South African families and healthcare professionals. As pioneers in reproductive health, we provide advanced, scientifically backed solutions to cater to the unique needs of our South African community and beyond.
CarrierScreen
CarrierScreen is a preconception reproductive health test for couples planning a pregnancy. It identifies genes linked to inherited genetic conditions that could be passed to a child, supporting informed family planning decisions with healthcare guidance.
PGT
Preimplantation Genetic Testing (PGT) is used alongside IVF to screen embryos for specific genetic or chromosomal abnormalities before implantation, helping guide embryo selection and support improved IVF outcomes.
Endometrial Health
Endometrial health testing evaluates the receptivity, or readiness, of the uterine lining to determine the optimal window for embryo transfer during IVF. It also assesses the endometrial microbiome to ensure a healthy uterine environment that supports embryo implantation. The results help guide personalised embryo transfer and informed clinical decision-making throughout IVF treatment cycles.
TriScreen
TriScreen is a non-invasive prenatal screening test available from 10 weeks of pregnancy. It assesses the risk of chromosomal conditions in the unborn baby using a simple maternal blood sample, with no risk to the mother or the baby.
POCScreen
POCScreen is a reproductive health testing service performed on miscarriage tissue to identify chromosomal abnormalities that may have contributed to pregnancy loss. The results can support reproductive counselling and guide future care decisions with a healthcare professional.
MiniMi
MiniMi is a non-invasive prenatal test available from 10 weeks of pregnancy to determine if your baby is a girl or boy. It uses a simple maternal blood sample to analyse placental DNA circulating in the mother’s bloodstream.
Netcells
Netcells offers stem cell banking as part of long-term reproductive and family health planning. Families can safely preserve cord blood and cord tissue at birth for potential future medical, therapeutic and regenerative use.
Together, we empower the future of reproductive health through informed reproductive health testing. Take the first step in your reproductive journey with confidence
Frequently Asked Questions
Find answers to common questions about Reproductive Health:
Reproductive health testing uses genetic and prenatal screening to assess potential risks before or during pregnancy. These tests help identify genetic conditions, chromosomal abnormalities, and other factors that may influence pregnancy outcomes. Results are used to support informed family planning and pregnancy care with a healthcare professional.
Reproductive health testing may be recommended for individuals or couples planning a pregnancy, those undergoing fertility or IVF treatment, and expectant parents seeking prenatal screening. A healthcare professional can advise which tests are appropriate based on individual circumstances.
No. Reproductive health testing supports the reproductive and pregnancy journey but does not replace fertility or IVF treatment. These tests are often used alongside fertility care to provide additional genetic insight and help guide clinical decision-making.
Some reproductive health tests are performed before conception, while others are available during early pregnancy. Non-invasive prenatal testing (NIPT), for example, can be performed from as early as 10 weeks. The timing depends on the specific test and clinical need.
Yes. Reproductive health testing is offered in collaboration with qualified healthcare professionals who assess suitability, request testing, and interpret results as part of ongoing care.
Turnaround times vary depending on the type of test performed. Some screening results may be available within days, while more complex genetic tests can take several weeks. Your healthcare provider will confirm expected timelines.
Reproductive health testing cannot prevent genetic conditions, but it can help identify risks early. This allows individuals, families, and healthcare professionals to make informed decisions about care, treatment options, or further testing.